Mannose Binding Lectin and Soluble Toll-like Receptor 2 in Heart Failure Following Acute Myocardial Infarction

Journal of Cardiac Failure

Volumn 12, Issue 8, 2006, Pages 659-663

  Ueland, Thor ^a,b   Espevik, Terje ^e   Kjekshus, John ^b   Gullestad, Lars ^b   Omland, Torbjørn ^c   Squire, Iain B ^f   Frøland, Stig S ^a,b   Mollnes, Tom E ^b   Dickstein, Kenneth ^d   Aukrust, Pål ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

^e NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^f UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Acute myocardial infarction; Heart failure; Innate immunity; Mannose binding lectin; Soluble Toll like receptor

Indexed keywords

MANNOSE BINDING LECTIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ATHEROGENESIS; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HEART REINFARCTION; HUMAN; IMMUNE RESPONSE; IMMUNITY; INFLAMMATION; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

AGED; BIOLOGICAL MARKERS; CARDIAC OUTPUT, LOW; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; IMMUNITY, NATURAL; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; SURVIVAL ANALYSIS; TIME FACTORS; TOLL-LIKE RECEPTOR 2;

EID: 33749598797     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2006.07.002     Document Type: Article

References (20)

1. Hansson G.K., Libby P., Schonbeck U., and Yan Z.Q. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 91 (2002) 281-291
2. Michelsen K.S., Doherty T.M., Shah P.K., and Arditi M. TLR signaling: an emerging bridge from innate immunity to atherogenesis. J Immunol 173 (2004) 5901-5907
3. Xu X.H., Shah P.K., Faure E., Equils O., Thomas L., Fishbein M.C., et al. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104 (2001) 3103-3108
4. Edfeldt K., Swedenborg J., Hansson G.K., and Yan Z.Q. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105 (2002) 1158-1161
5. Rugonfalvi-Kiss S., Endresz V., Madsen H.O., Burian K., Duba J., Prohaszka, et al. Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin. Circulation 106 (2002) 1071-1076
6. Hegele R.A., Ban M.R., Anderson C.M., and Spence J.D. Infection-susceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area. J Invest Med 48 (2000) 198-202
7. Saevarsdottir S., Oskarsson O.O., Aspelund T., Eiriksdottir G., Vikingsdottir T., Gudnason V., et al. Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk. J Exp Med 201 (2005) 117-125
8. Frantz S., Kelly R.A., and Bourcier T. Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes. J Biol Chem 276 (2001) 5197-5203
9. Shishido T., Nozaki N., Yamaguchi S., Shibata Y., Nitobe J., Miyamoto T., et al. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 108 (2003) 2905-2910
10. LeBouder E., Rey-Nores J.E., Rushmere N.K., Grigorov M., Lawn S.D., Affolter M., et al. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J Immunol 171 (2003) 6680-6689
11. Dickstein K., and Kjekshus J. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan. Lancet 360 (2002) 752-760
12. Ueland T., Jemtland R., Godang K., Kjekshus J., Hognestad A., Omland T., et al. Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction. J Am Coll Cardiol 44 (2004) 1970-1976
13. Fiane A.E., Videm V., Lingaas P.S., Heggelund L., Nielsen E.W., Geiran O.R., et al. Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair. Circulation 108 (2003) 849-856
14. Heggelund L., Flo T., Berg K., Lien E., Mollnes T.E.U.T.A.P., Espevik T., et al. Soluble toll-like receptor 2 in HIV infection: association with disease progression. AIDS 18 (2004) 2437-2439
15. Omland T., Persson A., Ng L., O'Brien R., Karlsson T., Herlitz J., et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 106 (2002) 2913-2918
16. Soborg C., Madsen H.O., Andersen A.B., Lillebaek T., Kok-Jensen A., Garred P., et al. Mannose-binding lectin polymorphisms in clinical tuberculosis. J Infect Dis 188 (2003) 777-782
17. Knuefermann P., Nemoto S., Baumgarten G., Mirsa A., Sivasubramanian N., Carabello B.A., et al. Cardiac inflammation and innate immunity in septic shock: is there a role for toll-like receptors?. Chest 121 (2002) 1329-1336
18. Ameziane N., Beillat T., Verpillat P., Chollet-Martin S., Aumont M.C., Seknadji P., et al. Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 23 (2003) e61-e64
19. Boekholdt S.M., Agema W.R., Peters R.J., Zwinderman A.H., van der Wall E.E., Reitsma P.H., et al. Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation 107 (2003) 2416-2421
20. Madsen H.O., Videm V., Svejgaard A., Svennevig J.L., and Garred P. Association of mannose-binding-lectin deficiency with severe atherosclerosis. Lancet 352 (1998) 959-960